Senior Director, Clinical Lab Operations at Tempus

Durham, North Carolina, United States

Tempus Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Precision MedicineIndustries

Requirements

  • Bachelor’s in medical technology, clinical laboratory science, chemical, physical or biological science
  • Experience with molecular biology and Next Generation Sequencing (NGS)
  • Experience supervising others in a CLIA/CAP high-complexity laboratory
  • Minimum of 7+ years working in a clinical lab
  • Experience with NYSDOH and GCLP regulations (highly desirable)
  • Experience with analytical and clinical validations (highly desirable)
  • Excellent communication skills
  • Ability to delegate tasks to others
  • Thrives in a fast-paced environment
  • Self-driven and works well in an interdisciplinary team with minimal direction
  • Strong desire to build products that will save lives and change the course of cancer
  • Impeccable attention to detail

Responsibilities

  • Oversee the strategic operations of a cutting-edge, high-volume clinical laboratory to support next-generation sequencing workflow with rapid turnaround times
  • Deliver regular updates to executive team summarizing laboratory performance, turnaround times, instrument downtime, productivity, and other performance metrics
  • Contribute to laboratory capacity planning for personnel, capital equipment, and space
  • Work with inter-departmental team leaders to build efficiencies and streamline processes
  • Advocate for laboratory processes during development of Laboratory Information Systems (LIS) and other data systems
  • Ensure regulatory compliance within the lab, including CAP, CLIA, NYSDOH, GCLP, and OSHA
  • Monitor laboratory proficiency testing and quality control trends; ensure corrective and preventative actions are taken whenever test systems deviate from the laboratory’s established performance specifications
  • Collaborate with assay development team to ensure successful tech transfer of new products to the clinical lab
  • Possess a deep working knowledge of technical equipment and processes and find efficiencies for improved workflow and performance
  • Deliver laboratory efficiencies and error-reduction through automation and process engineering
  • Oversee the laboratory training program to ensure training protocols are sufficient
  • Provide technical direction, mentoring, and professional guidance to laboratory employees
  • Attract and retain top talent; create growth opportunities for staff

Skills

Next-Generation Sequencing
Laboratory Operations
CAP
CLIA
NYSDOH
GCLP
OSHA
Laboratory Information Systems
Quality Control
Process Engineering
Automation
Tech Transfer
Regulatory Compliance
Proficiency Testing

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI